SCHEMBL5720784

SCHEMBL5720784

CCCCOC(=O)Nc1ccc(S)cc1C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.55
CYP1A2 P05177 3/20 0.55
CYP2C19 P33261 3/20 0.55
HPGD P15428 6/20 0.52
ALDH1A1 P00352 4/20 0.52
L3MBTL1 Q9Y468 3/20 0.52
KDM4E B2RXH2 2/20 0.52
PLK1 P53350 3/20 0.49
LMNA P02545 2/20 0.47
TSHR P16473 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
RAB9A P51151 7/20 0.46
POLB P06746 1/20 0.46
NPC1 O15118 6/20 0.45
CYP2C9 P11712 2/20 0.45
CASP1 P29466 1/20 0.45
MAPT P10636 1/20 0.45
MAPK1 P28482 1/20 0.45
MCL1 Q07820 1/20 0.45
AKR1C2 P52895 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10489932 0.84 CYP1A2 (0.59) SMN1; SMN2CYP1A2CYP2C19HPGDALDH1A1
SCHEMBL10490025 0.83 CYP1A2 (0.54) SMN1; SMN2CYP1A2CYP2C19HPGDALDH1A1
SCHEMBL10489833 0.83 METAP2 (0.55) SMN1; SMN2CYP1A2CYP2C19HPGDALDH1A1
SCHEMBL4839353 0.82 PLK1 (0.67) SMN1; SMN2CYP1A2CYP2C19HPGDALDH1A1
SCHEMBL2320061 0.81 SMN1; SMN2 (0.77) SMN1; SMN2CYP1A2CYP2C19HPGDALDH1A1
SCHEMBL5228861 0.80 CYP1A2 (0.54) SMN1; SMN2CYP1A2CYP2C19HPGDALDH1A1
SCHEMBL19778994 0.80 SMN1; SMN2 (0.53) SMN1; SMN2CYP1A2CYP2C19HPGDALDH1A1
SCHEMBL8108517 0.78 PLK1 (0.63) SMN1; SMN2CYP1A2CYP2C19HPGDALDH1A1
SCHEMBL10489746 0.78 METAP2 (0.55) SMN1; SMN2CYP1A2CYP2C19KDM4EPLK1
SCHEMBL27685659 0.76 SMN1; SMN2 (0.59) SMN1; SMN2CYP1A2CYP2C19HPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1611089-A2 HYDROXYETHYLAMINE COMPOUNDS HAVING ASP2 INHIBITORY ACTIVITY FOR THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LIMITED (GB) 2006-01-04 EP disclosed
WO-2004080376-A2 HYDROXYETHYLAMINE COMPOUNDS HAVING ASP2 INHIBITORY ACTIVITY FOR THE TREATMENT OF ALZHEIMER’S DISEASE GLAXO GROUP LIMITED (GB) 2004-09-23 WO disclosed